Mucopolysaccharidosis
RareMetabolic
Mucopolysaccharidosis is treated with 1 medication in our database, including MEPSEVII. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Ultragenyx. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Mucopolysaccharidosis treatment below.
What help exists for Mucopolysaccharidosis
5
drugs indexed
4
with copay cards
4
with patient assistance
2
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Mucopolysaccharidosis
5 totalMEPSEVII
vestronidase alfa · Ultragenyx
🎟💙ELAPRASE
idursulfase · Takeda
ALDURAZYME
laronidase · Sanofi
🎟💙NAGLAZYME
galsulfase · BioMarin
🎟💙VIMIZIM
elosulfase alfa · BioMarin
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Mucopolysaccharidosis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Mucopolysaccharidosis patients
3 total · 2 openMucopolysaccharidosis is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →